Senseonics closes $92M public offering, fully exercises underwriters’ option for shares.

Senseonics Holdings, Inc., a medical tech company specializing in implantable glucose monitoring systems, has closed a public offering raising $92 million. The company sold 10.4 million common shares, including 2.4 million additional shares from the underwriters’ option, plus 8 million pre-funded warrants. The proceeds will support the development and commercialization of their long-term glucose monitoring products. This financing strengthens Senseonics' position in the diabetes care market as it advances its technology and expands its offerings.